Release Date: 26/09/12 16:40 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 183.82KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%